Your new post is loading...
Given the usual hype surrounding small-cap biotechs, Brainstorm CEO Tony Fiorino is refreshingly candid about the company's chances of developing a stem-cell treatment to counter ALS symptoms.
Scoop.it!
No comment yet.
Sign up to comment
